These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4369021)

  • 21. Changes in membrane polypeptides that occur when chick embryo fibroblasts and NRK cells are transformed with avian sarcoma viruses.
    Stone KR; Smith RE; Joklik WK
    Virology; 1974 Mar; 58(1):86-100. PubMed ID: 4362554
    [No Abstract]   [Full Text] [Related]  

  • 22. The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants.
    Fairbairn S; Gilbert R; Ojakian G; Schwimmer R; Quigley JP
    J Cell Biol; 1985 Nov; 101(5 Pt 1):1790-8. PubMed ID: 2997235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiplicity of rabbit plasminogen. Physical characterization.
    Sodetz JM; Brockway WJ; Castellino FJ
    Biochemistry; 1972 Nov; 11(24):4451-8. PubMed ID: 4653125
    [No Abstract]   [Full Text] [Related]  

  • 24. [(0)-forms of RNA-containing oncogenic viruses as a model of latent infection].
    Irlin IS
    Vestn Akad Med Nauk SSSR; 1973; 28(2):28-33. PubMed ID: 4359443
    [No Abstract]   [Full Text] [Related]  

  • 25. Properties of plasminogen activators formed by neoplastic human cell cultures.
    Rifkin DB; Loeb JN; Moore G; Reich E
    J Exp Med; 1974 May; 139(5):1317-28. PubMed ID: 4207624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The carbohydrate content of control and virus-transformed cells.
    Hartmann JF; Buck CA; Defendi V; Glick MC; Warren L
    J Cell Physiol; 1972 Oct; 80(2):159-65. PubMed ID: 4344772
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of morphologic revertants of murine and avian sarcoma virus-transformed cells.
    Stephenson JR; Reynolds RK; Aaronson SA
    J Virol; 1973 Feb; 11(2):218-22. PubMed ID: 4347425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral genome and oncogenic transformation: nuclear and plasma membrane events.
    Meyer G
    Adv Cancer Res; 1971; 14():71-159. PubMed ID: 4330475
    [No Abstract]   [Full Text] [Related]  

  • 29. Transformation-enhancing factor(s) released from chicken Rous sarcoma cells: effect on some transformation parameters.
    Kryceve-Martinerie C; Biquard JM; Lawrence D; Vigier P; Barlati S; Mignatti P
    Virology; 1981 Jul; 112(2):436-49. PubMed ID: 6266136
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell surface antigen induced by avian tumor viruses in hamster cells transformed by a temperature-sensitive mutant of Rous sarcoma virus.
    Aupoix Michèle C; Biquard JM; Cachard A
    Int J Cancer; 1974 Nov; 14(5):611-6. PubMed ID: 4142473
    [No Abstract]   [Full Text] [Related]  

  • 31. Transformation of rat liver cells with chicken sarcoma virus B77 and murine sarcoma virus.
    Altaner C; Hlavayova E
    J Virol; 1973 Feb; 11(2):177-82. PubMed ID: 4347422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversion in virus-transformed cells.
    Macpherson I
    Biochem Pharmacol; 1971 May; 20(5):1005-8. PubMed ID: 4333939
    [No Abstract]   [Full Text] [Related]  

  • 33. DNA polymerases in human lymphoblastoid cells infected with simian sarcoma virus.
    Lewis BJ; Abrell JW; Smith RG; Gallo RC
    Biochim Biophys Acta; 1974 May; 349(2):148-60. PubMed ID: 4135147
    [No Abstract]   [Full Text] [Related]  

  • 34. A quantitative assay for the activation of plasminogen by transformed cells in situ and by urokinase.
    Leytus SP; Peltz GA; Liu HY; Cannon JF; Peltz SW; Livingston DC; Brocklehurst JR; Mangel WF
    Biochemistry; 1981 Jul; 20(15):4307-14. PubMed ID: 7025895
    [No Abstract]   [Full Text] [Related]  

  • 35. Absence of RSV production in enucleated RSV-transformed virogenic Mammalian cells fused with chick embryo fibroblasts.
    Donner L; Turek L; Svoboda J
    Int J Cancer; 1974 Nov; 14(5):657-61. PubMed ID: 4376530
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of protease activity in cultures of rous sarcoma virus-transformed cells: effect on the transformed phenotype.
    Weber MJ
    Cell; 1975 Jul; 5(3):253-61. PubMed ID: 167981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid.
    Claeys H; Vermylen J
    Biochim Biophys Acta; 1974 Apr; 342(2):351-9. PubMed ID: 4275496
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective lysis of cells transformed by Rous Sarcoma virus.
    Rifkin DB; Reich E
    Virology; 1971 Jul; 45(1):172-81. PubMed ID: 4329586
    [No Abstract]   [Full Text] [Related]  

  • 39. Streptokinase-dependent delayed activation of horse plasminogen.
    Marcum JA; Highsmith RF; Kline DL
    Biochim Biophys Acta; 1982 Dec; 709(1):19-27. PubMed ID: 6217838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity chromatography of avian type C viral reverse transcriptase: studies with Rous sarcoma virus transformed rat cells.
    Livingston DM; Parks WP; Scolnick EM; Ross J
    Virology; 1972 Nov; 50(2):388-95. PubMed ID: 4117933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.